Analysis
2012
5/14/2012
Introduction
This report pertains to the analysis of the companies Pfizer Inc and Sanofi S.A. Pfizer Inc is a major player in the global pharmaceutical industry and is driven by the vision of improving the life and health of the consumers through innovative discoveries and solutions. The company is diversified geographically and the global healthcare portfolio comprises of human as well as animal biologic & vaccines and small molecule medicines along with a broad range of nutritional products. It also markets several of the globe’s best−known products related to consumer healthcare. On the other hand, Sanofi S.A. is a major pharmaceutical company headquartered in France and is also the world’s fourth largest company in terms of prescription sales. The company is a well diversified global healthcare company which is engaged in the activities of research, development as well as manufacturing and marketing of various healthcare products. It deals in pharmaceuticals which comprises of prescription drugs, vaccines and animal health as well as consumer healthcare and generics.
I. Corporate Governance
A. The Chief Executive Officer
i) The CEO of the company Pfizer Inc is Mr. Ian Read. He has been the CEO of the company since 2011. Mr. Chris Viehbacher is the CEO of Sanofi and he has been in office since December 1, 2008 ii) Pfizer is not a family run company. Mr. Read has been associated with Pfizer since 1978. He joined Pfizer as an operational auditor. Since then, he worked in Latin America through the year 1995 and held various positions in several of Pfizer's largest and most rapidly growing operations, such as the Chief Financial Officer of the unit Pfizer Mexico, and the Country Manager of the unit Pfizer Brazil. He was then appointed as the President of Pfizer's International Pharmaceuticals Group in 1996 and was given the responsibility for managing the operations in Canada and Latin